An artificial-intelligence approach created at Carolina could help bring new drugs to patients quicker.
An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.
The system is called Reinforcement Learning for Structural Evolution, known as ReLeaSE, and is an algorithm and computer program that comprises two neural networks which can be thought of as a teacher and a student. The teacher knows the syntax and linguistic rules behind the vocabulary of chemical structures for about 1.7 million known biologically active molecules. By working with the teacher, the student learns over time and becomes better at proposing molecules that are likely to be useful as new medicines.
Alexander Tropsha, Olexandr Isayev and Mariya Popova, all of the UNC Eshelman School of Pharmacy, are the creators of ReLeaSE. The University has applied for a patent for the technology, and the team published a proof-of-concept study in the journal Science Advances last week.
“If we compare this process to learning a language, then after the student learns the molecular alphabet and the rules of the language, they can create new ‘words,’ or molecules,” said Tropsha. “If the new molecule is realistic and has the desired effect, the teacher approves. If not, the teacher disapproves, forcing the student to avoid bad molecules and create good ones.”
ReLeaSE is a powerful innovation to virtual screening, the computational method widely used by the pharmaceutical industry to identify viable drug candidates. Virtual screening allows scientists to evaluate existing large chemical libraries, but the method only works for known chemicals. ReLeASE has the unique ability to create and evaluate new molecules.
“A scientist using virtual screening is like a customer ordering in a restaurant. What can be ordered is usually limited by the menu,” said Isayev. “We want to give scientists a grocery store and a personal chef who can create any dish they want.”
The team has used ReLeaSE to generate molecules with properties that they specified, such as desired bioactivity and safety profiles.The team used the ReLeaSE method to design molecules with customized physical properties, such as melting point and solubility in water, and to design new compounds with inhibitory activity against an enzyme that is associated with leukemia.
“The ability of the algorithm to design new, and therefore immediately patentable, chemical entities with specific biological activities and optimal safety profiles should be highly attractive to an industry that is constantly searching for new approaches to shorten the time it takes to bring a new drug candidate to clinical trials,” said Tropsha.
Learn more: Artificial intelligence system created at UNC-Chapel Hill designs drugs from scratch
The Latest on: Drug design
[google_news title=”” keyword=”drug design” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug design
- Fake designer products likely benefit cartels, other organized crime rings: CBPon March 22, 2023 at 10:25 pm
The scheme can be likely traced to organized crime groups around the world, including drug cartels, the Russian mob and the Asian mob, authorities say.
- Understanding the structure of CFTR could help design more effective therapies for cystic fibrosison March 22, 2023 at 9:54 pm
Current therapies using a drug called a potentiator can enhance CFTR functions ... With this information, researchers may be able to design more effective therapies for cystic fibrosis. The study was ...
- FDA advisers support conditional clearance of Biogen’s ALS drugon March 22, 2023 at 4:59 pm
Though the drug, called tofersen, missed the main goal of a key clinical trial, it showed an effect on a protein tied to ALS. Experts see that as a good sign, but some worry Biogen has not yet ...
- Customs and Border Protection seizes two parcels of knockoff designer items at O'Hareon March 22, 2023 at 1:41 pm
Proceeds from the sale of counterfeit goods can go toward criminal organizations that are involved in such activity as money laundering and drug trafficking ... Texas – CBP officers found counterfeit ...
- Disturbing Findings: Child Drug Use Vastly Underestimatedon March 21, 2023 at 8:18 pm
Experts recommend future substance use research should combine survey and hair analysis results. Hair analysis could be the key to understanding adolescent drug usage, as a new study uncovers almost d ...
- Schizophrenia Drug May Offer Much-Needed Progresson March 21, 2023 at 12:54 am
Late-stage data on a treatment in development by Karuna Therapeutics show promise on sharply reducing harsh side effects.
- Drug dealer was buying 'massive amounts' of designer clothingon March 20, 2023 at 6:00 pm
Roshan Walker was at Oxford Crown Court on Monday, when he pleaded guilty to dealing drugs in Banbury last February.
- Designing a Drug-Delivery Device? Read This Firston March 19, 2023 at 5:00 pm
Injecting the drug under the skin with the help of syringes is mostly dependent upon the fluid properties of the drug. The design of delivery devices or syringes is based on fluid properties of the ...
- DNA treatment could delay paralysis that strikes nearly all patients with ALSon March 19, 2023 at 2:08 pm
Researchers use a DNA designer drug to restore key protein levels in motor neurons, delaying paralysis in a mouse model of ALS. In virtually all persons with amyotrophic lateral sclerosis (ALS ...
via Bing News